NeuroOne Medical Technologies

NeuroOne Medical Technologies Gross Margin

The Gross Margin of NeuroOne Medical Technologies (NMTC) as of Nov 5, 2026 is 67.30 %. In the previous year, Gross Margin was 31.27 % — a change of 115.23% (higher).

Gross Margin

67.30 %

YoY

115.23%

Last updated:

Gross Margin of NeuroOne Medical Technologies is 2025 67.30 % . Gross Margin of NeuroOne Medical Technologies was 2024 31.27 % . It decreases by 115.23% higher compared to the previous year.

NeuroOne Medical Technologies's gross margin stands at 67.3%, up from -54.9% several years earlier.

The NeuroOne Medical Technologies Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2015
100.00 USD
Jan 1, 2016
100.00 USD
Jan 1, 2020
96.34 USD
Jan 1, 2021
-54.87 USD
Jan 1, 2022
-41.36 USD
Jan 1, 2023
23.38 USD
Jan 1, 2024
31.27 USD
Jan 1, 2025
67.30 USD
The NeuroOne Medical Technologies Gross Margin history
YEARGross MarginYoY
67.30 %+115.23%
31.27 %+33.73%
23.38 %-156.53%
-41.36 %-24.62%
-54.87 %-156.96%
96.34 %-3.66%
100.00 %0.00%
100.00 %0.00%
100.00 %+9,900.00%
1.00 %0.00%
1.00 %+65.58%
0.60 %-39.61%
1.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

NeuroOne Medical Technologies Stock analysis

What does NeuroOne Medical Technologies do? NeuroOne Medical Technologies Corp., based in Eden Prairie, Minnesota, develops and commercializes thin film electrode technology for medical applications. The company focuses on continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for neurological disorders such as epilepsy, Parkinson's disease, and chronic pain. Listed on the stock market in 2012, NeuroOne employs 15 people and explores AI applications in its technology. NeuroOne Medical Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NeuroOne Medical Technologies stock

Gross Margin of NeuroOne Medical Technologies is 67.30 % in 2025.

Gross Margin of NeuroOne Medical Technologies changed from 31.27 % to 67.30 %, representing a 115.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin NeuroOne Medical Technologies since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's NeuroOne Medical Technologies with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — NeuroOne Medical Technologies

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — NeuroOne Medical Technologies